Arvinas, Inc. (ARVN)
NASDAQ·Healthcare·Biotechnology
$8.21
+0.12%
Mkt Cap $523.91M
Analyst Ratings
Buy
9
Hold
1
Sell
0
Price Target (36 analysts)
$14.75
Range $10.00 – $20.00
Implied Upside
+79.7%
Consensus $14.75 vs current $8.21
NASDAQ·Healthcare·Biotechnology
$8.21
+0.12%
Mkt Cap $523.91M
Buy
9
Hold
1
Sell
0
Price Target (36 analysts)
$14.75
Range $10.00 – $20.00
+79.7%
Consensus $14.75 vs current $8.21